Diagnostic Value of Targeted Next-generation Sequencing in Pulmonary Mycobacterial Infections.

IF 2 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Current Medical Science Pub Date : 2024-10-01 Epub Date: 2024-10-05 DOI:10.1007/s11596-024-2937-4
Yu Tao, Zi-Wei Zhou, Yi-Fei Duan, Jian-Miao Wang
{"title":"Diagnostic Value of Targeted Next-generation Sequencing in Pulmonary Mycobacterial Infections.","authors":"Yu Tao, Zi-Wei Zhou, Yi-Fei Duan, Jian-Miao Wang","doi":"10.1007/s11596-024-2937-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore the diagnostic value of novel technique-targeted next-generation sequencing (tNGS) of bronchoalveolar lavage fluid (BALF) in pulmonary mycobacterial infections.</p><p><strong>Methods: </strong>This retrospective study was conducted on patients who underwent bronchoscopy and tNGS, smear microscopy, and mycobacterial culture of BALF. Patients with positive Mycobacterium tuberculosis (MTB) culture or GeneXpert results were classified into the tuberculosis case group. Those diagnosed with nontuberculous mycobacteria (NTM)-pulmonary disease (NTM-PD) composed the case group of NTM-PD patients. The control group comprised patients without tuberculosis or NTM-PD. Sensitivity, specificity, and receiver operating characteristic (ROC) curves were used to evaluate the diagnostic performance.</p><p><strong>Results: </strong>For tuberculosis patients with positive mycobacterial culture results, the areas under the ROC curves (AUCs) for tNGS, GeneXpert, and smear microscopy were 0.975 (95% CI: 0.935, 1.000), 0.925 (95% CI: 0.859, 0.991), and 0.675 (95% CI: 0.563, 0.787), respectively. For tuberculosis patients with positive GeneXpert results, the AUCs of tNGS, culture, and smear microscopy were 0.970 (95% CI: 0.931, 1.000), 0.850 (95% CI: 0.770, 0.930), and 0.680 (95% CI: 0.579, 0.781), respectively. For NTM-PD, the AUCs of tNGS, culture, and smear-positive but GeneXpert-negative results were 0.987 (95% CI: 0.967, 1.000), 0.750 (95% CI: 0.622, 0.878), and 0.615 (95% CI: 0.479, 0.752), respectively. The sensitivity and specificity of tNGS in NTM-PD patients were 100% and 97.5%, respectively.</p><p><strong>Conclusion: </strong>tNGS demonstrated superior diagnostic efficacy in mycobacterial infection, indicating its potential for clinical application.</p>","PeriodicalId":10820,"journal":{"name":"Current Medical Science","volume":" ","pages":"947-953"},"PeriodicalIF":2.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11596-024-2937-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This study aimed to explore the diagnostic value of novel technique-targeted next-generation sequencing (tNGS) of bronchoalveolar lavage fluid (BALF) in pulmonary mycobacterial infections.

Methods: This retrospective study was conducted on patients who underwent bronchoscopy and tNGS, smear microscopy, and mycobacterial culture of BALF. Patients with positive Mycobacterium tuberculosis (MTB) culture or GeneXpert results were classified into the tuberculosis case group. Those diagnosed with nontuberculous mycobacteria (NTM)-pulmonary disease (NTM-PD) composed the case group of NTM-PD patients. The control group comprised patients without tuberculosis or NTM-PD. Sensitivity, specificity, and receiver operating characteristic (ROC) curves were used to evaluate the diagnostic performance.

Results: For tuberculosis patients with positive mycobacterial culture results, the areas under the ROC curves (AUCs) for tNGS, GeneXpert, and smear microscopy were 0.975 (95% CI: 0.935, 1.000), 0.925 (95% CI: 0.859, 0.991), and 0.675 (95% CI: 0.563, 0.787), respectively. For tuberculosis patients with positive GeneXpert results, the AUCs of tNGS, culture, and smear microscopy were 0.970 (95% CI: 0.931, 1.000), 0.850 (95% CI: 0.770, 0.930), and 0.680 (95% CI: 0.579, 0.781), respectively. For NTM-PD, the AUCs of tNGS, culture, and smear-positive but GeneXpert-negative results were 0.987 (95% CI: 0.967, 1.000), 0.750 (95% CI: 0.622, 0.878), and 0.615 (95% CI: 0.479, 0.752), respectively. The sensitivity and specificity of tNGS in NTM-PD patients were 100% and 97.5%, respectively.

Conclusion: tNGS demonstrated superior diagnostic efficacy in mycobacterial infection, indicating its potential for clinical application.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肺分枝杆菌感染中靶向新一代测序的诊断价值。
研究目的本研究旨在探讨支气管肺泡灌洗液(BALF)的新型靶向新一代测序技术(tNGS)在肺分枝杆菌感染中的诊断价值:这项回顾性研究的对象是接受支气管镜检查和 tNGS、涂片镜检以及 BALF 分枝杆菌培养的患者。结核分枝杆菌(MTB)培养或 GeneXpert 结果呈阳性的患者被归入结核病例组。被确诊为非结核分枝杆菌(NTM)-肺部疾病(NTM-PD)的患者组成非结核分枝杆菌-肺部疾病病例组。对照组由没有结核病或非结核分枝杆菌肺病的患者组成。灵敏度、特异性和接收器操作特征曲线(ROC)用于评估诊断效果:对于分枝杆菌培养结果呈阳性的肺结核患者,tNGS、GeneXpert 和涂片镜检的 ROC 曲线下面积(AUC)分别为 0.975(95% CI:0.935,1.000)、0.925(95% CI:0.859,0.991)和 0.675(95% CI:0.563,0.787)。对于 GeneXpert 结果呈阳性的结核病患者,tNGS、培养和涂片镜检的 AUC 分别为 0.970(95% CI:0.931,1.000)、0.850(95% CI:0.770,0.930)和 0.680(95% CI:0.579,0.781)。对于 NTM-PD,tNGS、培养和涂片阳性但 GeneXpert 阴性结果的 AUC 分别为 0.987(95% CI:0.967,1.000)、0.750(95% CI:0.622,0.878)和 0.615(95% CI:0.479,0.752)。在 NTM-PD 患者中,tNGS 的敏感性和特异性分别为 100% 和 97.5%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current Medical Science
Current Medical Science Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
4.70
自引率
0.00%
发文量
126
期刊介绍: Current Medical Science provides a forum for peer-reviewed papers in the medical sciences, to promote academic exchange between Chinese researchers and doctors and their foreign counterparts. The journal covers the subjects of biomedicine such as physiology, biochemistry, molecular biology, pharmacology, pathology and pathophysiology, etc., and clinical research, such as surgery, internal medicine, obstetrics and gynecology, pediatrics and otorhinolaryngology etc. The articles appearing in Current Medical Science are mainly in English, with a very small number of its papers in German, to pay tribute to its German founder. This journal is the only medical periodical in Western languages sponsored by an educational institution located in the central part of China.
期刊最新文献
Qiliqiangxin Alleviates Imbalance of Inflammatory Cytokines in Patients with Dilated Cardiomyopathy: A Randomized Controlled Trial. Brain-computer Interaction in the Smart Era. Contribution of ECT2 to Tubulointerstitial Fibrosis in the Progression of Chronic Kidney Disease. Performance Assessment of GPT 4.0 on the Japanese Medical Licensing Examination. Application and Prospects of Deep Learning Technology in Fracture Diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1